Pharmaceutical Engineering is delighted to announce the 2018 Roger F. Sherwood Article of the Year finalists. The articles were selected by the judges from 37 feature and technical articles published by Pharmaceutical Engineering during calendar year 2018 (volume 38).
A subcommittee of the Pharmaceutical Engineering Committee (PEC) served as judges for the 2018 award competition, reviewing articles and providing assessments on the following criteria: usefulness to ISPE readers; how the articles improve the knowledge of key topics; and clarity/ease of reading.
The PEC subcommittee was headed by Michelle Gonzalez. Thank you to Michelle and the PEC subcommittee for reviews and assessments!
Six finalists were identified. The Article of the Year award winner will be selected from these finalists, and will be announced shortly.
The Roger F. Sherwood Article of the Year award was established in 1993 to increase article submissions and improve the quality of those received. Although various judges have taken part in assessing articles over the years, one constant remains: recognition of quality and excellence in content through identifying finalists and a single winning article for each publication year.
“Pharmaceutical Engineering is proud to continue the tradition of recognizing the articles and authors who share their knowledge and research with ISPE members,” said Susan Sandler, Editorial Director for Pharmaceutical Engineering, PE Online, and the iSpeak blog. “Congratulations to this year’s finalists and we look forward to your future contributions to the magazine, the web site, and the blog.”
Submissions to Pharmaceutical Engineering are always welcome and any published submission could become a finalist for a future Article of the Year award!
The landscape of clinical trials has evolved significantly with the pandemic and interest in utilization of decentralized clinical trial (DCT) designs as a mitigation and the need for remote data collection. In response to this shift, the US Food and Drug Administration (US FDA) has released draft guidelines to try to provide clarity on the use of DCT models in clinical trials. While the...
The ongoing evolution of the pharmaceutical industry, aimed at propelling the next generation of medicines requires the close collaboration with regulators, emphasizing innovation, partnership, and a continued dedication to addressing patient needs. This transformation holds the potential to guide significant advancements in the development and delivery of medicines, leading to improved...
The pharmaceutical industry stands at the cusp of a transformative era, where the integration of sustainability within the supply chain is not just a trend, but a necessity. The 2024 ISPE Annual Meeting &...